Product Name:

TAOK1-pY309


Product Number:

ab-pk827

Price:

Regular price
$89.00
Regular price
Sale price
$89.00

Download Product PDF

Target Full Name: Serine/threonine-protein kinase TAO1

Target Alias: FLJ14314; HKFC-B; KIAA1361; MAP3K16; MARKK; PSK2; STE20-like kinase PSK2; TAOK1; TAO kinase 1; KFC-B; MARKK; h KFC-B; ENSG00000160551

Product Type Specific: Protein kinase phosphosite-specific antibody

Antibody Code: PK827

Antibody Target Type: Phosphosite-specific

Antibody Phosphosite: Y309

Protein UniProt: Q7L7X3

Protein SigNET: Q7L7X3

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human TAO1 (TAOK1) sequence peptide Cat. No.: PE-04APX95

Antibody Immunogen Sequence: NLQ(pY)RKM(bA)C

Antibody Immunogen Description: Corresponds to amino acid residues N306 to M312; Just after the kinase catalytic domain. Thhis is the major in vivo site of phosphorylation on TAO1.

Production Method: Corresponds to amino acid residues N306 to M312; Just after the kinase catalytic domain. Thhis is the major in vivo site of phosphorylation on TAO1.

Antibody Modification: Protein kinase phosphosite-specific antibody

Antibody Concentration: 1 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 2 µg/ml for immunoblotting

Antibody Potency: Strong immunoreactivity of a target-sized protein by Western blotting in HeLa cells and weak detection in HepG2 cells. Very strong immunoreactivity with immunogen peptide on dot blots.

Antibody Species Reactivity: Human

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 110-125 kDa.

Antibody Specificity: High

Antibody Cross Reactivity: No significant cross-reactive proteins detected in HepG2, MCF7 and T98G cells, except for ~80 kDa protein in HeLa cells and ~65 kDa protein in inulin-treated MCF7 cells.

Scientific Background: TAO1 (MAP3K16, TAOK1) is a protein-serine/threonine kinase of the STE group and STE20 family. It is involved in various processes such as p38/MAPK14 stress-activated MAPK cascade, DNA damage response and regulation of cytoskeleton stability. It phosphorylates MAP2K3, MAP2K6 and MARK2, and acts as an activator of the p38 (MAPK14) stress-activated MAPK cascade by phosphorylation and activation of the upstream MKK3 and MKK6 kinases. It is involved in G protein-coupled receptor signalling to p38 (MAPK14). In response to DNA damage, it is involved in the G2/M transition DNA damage checkpoint by activating the p38 (MAPK14) stress-activated MAPK cascade, probably by mediating phosphorylation of MKK3 (MAP2K3) and MKK6 (MAP2K6). It serves as a regulator of cytoskeleton stability by phosphorylating MARK2 at T208, leading to its activation and subsequent phosphorylation and detachment of MAPT/TAU from microtubules. It also regulates apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation via activation of the JNK (MAPK8) cascade.